FDA Approved: ZEJULA — Original Application (GlaxoSmithKline LLC)

View source ↗

Summary

FDA approved ZEJULA (niraparib) in an original application submitted by GlaxoSmithKline LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Zejula (Niraparib)

Snippet

ORIG AP for ZEJULA (NIRAPARIB)